Indeed, though both genes appear to be severely downregulated in chronic myeloid leukemia cells, the effect of Dasatinib on the HERC1 and HERC2 gene expression is different. This evidence concerns the gene HERC2 and chronic myelogenous leukemia, BCR-ABL1 positive.